Learning from the COVID-19 pandemic and considering the effects of this pandemic, we provide recommendations that can guide towards sustainable RSV surveillance with the potential to be integrated into the broader perspective of respiratory surveillance. https://bit.ly/40TsO0G

The emergence of SARS-CoV-2 and the resulting coronavirus disease 2019 (COVID-19) pandemic has led to the reconsideration of surveillance strategies for respiratory syncytial virus (RSV) and other respiratory viruses. The COVID-19 pandemic and the non-pharmaceutical interventions for COVID-19 had a substantial impact on RSV transmission in many countries, with close to no transmission detected during parts of the usual season of 2020–2021. Subsequent relaxation of social restrictions has resulted in unusual out-of-season resurgences of RSV in several countries, causing a higher healthcare burden and often a higher proportion of hospitalisations than usual among children older than 1 year in age [1]. In case of an emerging infectious disease with pandemic potential, preparedness to scale up surveillance for the emerging disease while continuing the maintenance of surveillance activities of pre-existing seasonal diseases is necessary.

Centre National de Référence des virus des infections respiratoires dont la grippe Hospices Civils de Lyon Lyon France

Department of Clinical Research Nordsjaellands Hospital and University of Copenhagen Department of Public Health Copenhagen Denmark

European Centre for Disease Prevention and Control Stockholm Sweden

Finnish National Institute for Health and Welfare Helsinki Finland

Foundazione PENTA Onlus Padova Italy

Health Protection Surveillance Centre Dublin Ireland

Independent researcher Edinburgh UK

Institut Pasteur Université Paris Cité CNRS UMR3569 Paris France

Instituto de Salud Carlos 3 Madrid CIBER de Epidemiología y Salud Pública Madrid Spain

National Institute for Public Health and the Environment Centre for Infectious Disease Control Bilthoven The Netherlands

National Institute of Health Ricardo Jorge Lisbon Portugal

National Institute of Public Health Ljubljana Slovenia

National Institute of Public Health NIH National Research Institute Warsaw Poland

National Institute of Public Health Prague Czech Republic

Netherlands Institute for Health Services Research Utrecht The Netherlands

Norwegian Institute of Public Health Oslo Norway

Public Health Agency of Sweden Stockholm Sweden

Riga East University Hospital Riga Latvia

Robert Koch Institute Berlin Germany

Statens Serum Institut Copenhagen Denmark

UK Health Security Agency London UK

Usher Institute University of Edinburgh Edinburgh UK

World Health Organization Geneva Switzerland

World Health Organization Regional Office for Europe Copenhagen Denmark

See more in PubMed

van Summeren J, Meijer A, Aspelund G, et al. . Low levels of respiratory syncytial virus activity in Europe during the 2020/21 season: what can we expect in the coming summer and autumn/winter? Euro Surveill 2021; 26: 2100639. doi:10.2807/1560-7917.ES.2021.26.29.2100639 PubMed DOI PMC

World Health Organization . End-to-end Integration of SARS-CoV-2 and Influenza Sentinel Surveillance: Revised Interim Guidance. WHO/2019-nCoV/Integrated_sentinel_surveillance/2022.1. Geneva, WHO, 2022.

World Health Organization . Maintaining Surveillance of Influenza and Monitoring SARS-CoV-2 – Adapting Global Influenza Surveillance and Response System (GISRS) and Sentinel Systems during the COVID-19 Pandemic. WHO/2019-nCoV/Adapting_GISRS/2020.1. Geneva, WHO, 2020.

Oh DY, Buda S, Biere B, et al. . Trends in respiratory virus circulation following COVID-19-targeted nonpharmaceutical interventions in Germany, January–September 2020: analysis of national surveillance data. Lancet Reg Health Eur 2021; 6: 100112. doi:10.1016/j.lanepe.2021.100112 PubMed DOI PMC

World Health Organization Regional Office for Europe . Strategy Considerations for Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Other Respiratory Viruses in the WHO European Region during Autumn and Winter 2022/23: Protecting the Vulnerable with Agility, Efficiency, and Trust. WHO/EURO:2022-5851-45616-65461. Copenhagen, WHO Regional Office for Europe, 2022.

World Health Organization and the European Centre for Disease Prevention and Control . Operational Considerations for Respiratory Virus Surveillance in Europe. WHO/EURO:2022-5841-45606-65427. Copenhagen/Stockholm, WHO Regional Office for Europe/ECDC, 2022.

Teirlinck AC, Broberg EK, Stuwitz Berg A, et al. . Recommendations for respiratory syncytial virus surveillance at the national level. Eur Respir J 2021; 58: 2003766. doi:10.1183/13993003.03766-2020 PubMed DOI PMC

Baker RE, Park SW, Yang W, et al. . The impact of COVID-19 nonpharmaceutical interventions on the future dynamics of endemic infections. Proc Natl Acad Sci USA 2020; 117: 30547–30553. doi:10.1073/pnas.2013182117 PubMed DOI PMC

European Medicines Agency . New Medicine to Protect Babies and Infants from Respiratory Syncytial Virus (RSV) Infection. Date last updated: 16 September 2022. https://www.ema.europa.eu/en/news/new-medicine-protect-babies-infants-respiratory-syncytial-virus-rsv-infection

Lowensteyn YN, Mazur NI, Nair H, et al. . Describing global pediatric RSV disease at intensive care units in GAVI-eligible countries using molecular point-of-care diagnostics: the RSV GOLD-III study protocol. BMC Infect Dis 2021; 21: 857. doi:10.1186/s12879-021-06544-3 PubMed DOI PMC

Jensen TO, Stelzer-Braid S, Willenborg C, et al. . Outbreak of respiratory syncytial virus (RSV) infection in immunocompromised adults on a hematology ward. J Med Virol 2016; 88: 1827–1831. doi:10.1002/jmv.24521 PubMed DOI

Korsten K, Adriaenssens N, Coenen S, et al. . Burden of respiratory syncytial virus infection in community-dwelling older adults in Europe (RESCEU): an international prospective cohort study. Eur Respir J 2021; 57: 2002688. doi:10.1183/13993003.02688-2020 PubMed DOI

Mao Z, Li X, Korsten K, et al. . Economic burden and health-related quality of life of respiratory syncytial virus and influenza infection in European community-dwelling older adults. J Infect Dis 2022; 226: Suppl. 1, S87–S94. doi:10.1093/infdis/jiac069 PubMed DOI

Shi T, Denouel A, Tietjen AK, et al. . Global disease burden estimates of respiratory syncytial virus-associated acute respiratory infection in older adults in 2015: a systematic review and meta-analysis. J Infect Dis 2020; 222: Suppl. 7, S577–SS83. doi:10.1093/infdis/jiz059 PubMed DOI

Childs A, Zullo AR, Joyce NR, et al. . The burden of respiratory infections among older adults in long-term care: a systematic review. BMC Geriatr 2019; 19: 210. doi:10.1186/s12877-019-1236-6 PubMed DOI PMC

French CE, McKenzie BC, Coope C, et al. . Risk of nosocomial respiratory syncytial virus infection and effectiveness of control measures to prevent transmission events: a systematic review. Influenza Other Respir Viruses 2016; 10: 268–290. doi:10.1111/irv.12379 PubMed DOI PMC

Schonning K, Dessau RB, Jensen TG, et al. . Electronic reporting of diagnostic laboratory test results from all healthcare sectors is a cornerstone of national preparedness and control of COVID-19 in Denmark. APMIS 2021; 129: 438–451. doi:10.1111/apm.13140 PubMed DOI PMC

Norwegian Institute of Public Health . Emergency Preparedness Register for COVID-19 (Beredt C19). Date last updated: 26 August 2021. www.fhi.no/en/id/infectious-diseases/coronavirus/emergency-preparedness-register-for-covid-19/

Thiam MM, Pontais I, Forgeot C, et al. . Syndromic surveillance: a key component of population health monitoring during the first wave of the COVID-19 outbreak in France, February–June 2020. PloS One 2022; 17: e0260150. doi:10.1371/journal.pone.0260150 PubMed DOI PMC

Williams TC, Lyttle MD, Cunningham S, et al. . Study pre-protocol for “BronchStart – the impact of the COVID-19 pandemic on the timing, age and severity of respiratory syncytial virus (RSV) emergency presentations; a multi-centre prospective observational cohort study”. Wellcome Open Res 2022; 6: 120. doi:10.12688/wellcomeopenres.16778.2 PubMed DOI PMC

Meissner HC. Viral bronchiolitis in children. N Engl J Med 2016; 374: 62–72. doi:10.1056/NEJMra1413456 PubMed DOI

Liu G, Qu J, Rose J, et al. . Roadmap for managing SARS-CoV-2 and other viruses in the water environment for public health. Engineering (Beijing) 2022; 12: 139–144. doi:10.1016/j.eng.2020.09.015 PubMed DOI PMC

Hughes B, Duong D, White BJ, et al. . Respiratory syncytial virus (RSV) RNA in wastewater settled solids reflects RSV clinical positivity rates. Environ Sci Technol Lett 2022; 9: 173–178.

Berbers G, Mollema L, van der Klis F, et al. . Antibody responses to respiratory syncytial virus: a cross-sectional serosurveillance study in the Dutch population focusing on infants younger than 2 years. J Infect Dis 2021; 224: 269–278. doi:10.1093/infdis/jiaa483 PubMed DOI PMC

Goya S, Galiano M, Nauwelaers I, et al. . Toward unified molecular surveillance of RSV: a proposal for genotype definition. Influenza Other Respir Viruses 2020; 14: 274–285. doi:10.1111/irv.12715 PubMed DOI PMC

Ramaekers K, Rector A, Cuypers L, et al. . Towards a unified classification for human respiratory syncytial virus genotypes. Virus Evol 2020; 6: veaa052. doi:10.1093/ve/veaa052 PubMed DOI PMC

Salimi V, Viegas M, Trento A, et al. . Proposal for human respiratory syncytial virus nomenclature below the species level. Emerg Infect Dis 2021; 27: 1–9. doi:10.3201/eid2706.204608 PubMed DOI PMC

Blanken MO, Rovers MM, Molenaar JM, et al. . Respiratory syncytial virus and recurrent wheeze in healthy preterm infants. N Engl J Med 2013; 368: 1791–1799. doi:10.1056/NEJMoa1211917 PubMed DOI

Hou N, Wang K, Zhang H, et al. . Comparison of detection rate of 16 sampling methods for respiratory viruses: a Bayesian network meta-analysis of clinical data and systematic review. BMJ Glob Health 2020; 5: e003053. doi:10.1136/bmjgh-2020-003053 PubMed DOI PMC

PROMISE Consortium . RSVLabNet – Establishing a Network of RSV Laboratories in Europe. https://imi-promise.eu/surveillance/rsvlabnet/

Domachowske JB, Anderson EJ, Goldstein M. The future of respiratory syncytial virus disease prevention and treatment. Infect Dis Ther 2021; 10: Suppl. 1, 47–60. doi:10.1007/s40121-020-00383-6 PubMed DOI PMC

European Centre for Disease Prevention and Control . COVID-19 Datasets. www.ecdc.europa.eu/en/covid-19/data

EU Commission . Commission Implementing Decision (EU) 2018/945 of 22 June 2018 on the Communicable Diseases and Related Special Health Issues to be Covered by Epidemiological Surveillance as well as Relevant Case Definitions. Brussels, Official Journal of the European Union, 2018.

InfluenzaNet . InfluenzaNet Analytics. www.influenzanet.info/

World Health Organization . WHO Strategy for Global Respiratory Syncytial Virus Surveillance based on the Influenza Platform. Geneva, WHO, 2019.